Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shirley D'Sa

Showing results (1-10 of 114) with videos related to

Pageof 12
Sort By:
Frontiers in Oncology|November 19, 2024
Review of BCL2 inhibitors for the treatment of Waldenström's macroglobulinaemia and non-IgM lymphoplasmacytic lymphomaOliver Tomkins, Shirley D'Sa
Expert Review of Hematology|December 16, 2025
Avoiding serious treatment-emergent adverse events in Waldenström macroglobulinemia patientsJahanzaib Khwaja, Jessica Rodrigues, Shirley D'Sa
British Journal of Haematology|October 31, 2018
Advances in POEMS treatment and the need to define standardised outcome measuresStephen Keddie, Shirley D'Sa, Michael P Lunn
Immunotherapy|August 10, 2022
Sutimlimab for treatment of cold agglutinin disease: why, how and for whom?Sigbjørn Berentsen, Wilma Barcellini, Shirley D'Sa, et al.
British Journal of Haematology|August 7, 2022
Evidence-based medical treatment of POEMS syndromeJahanzaib Khwaja, Shirley D'Sa, Michael P Lunn, et al.
British Journal of Haematology|June 20, 2019
High-dose therapy and autologous transplantation for POEMS Syndrome: effective, but how to optimise?Oliver Tomkins, Stephen Keddie, Michael P Lunn, et al.
American Journal of Hematology|July 12, 2020
Daratumumab for disabling cold agglutinin disease refractory to B-cell directed therapyOliver Tomkins, Sigbjørn Berentsen, Suzanne Arulogun, et al.
British Journal of Haematology|March 16, 2007
Guidelines for the use of imaging in the management of myelomaShirley D'Sa, Niels Abildgaard, Jane Tighe, et al.
British Journal of Haematology|December 21, 2002
Assessing diversity: immune reconstitution and T-cell receptor BV spectratype analysis following stem cell transplantationKarl S Peggs, Stephanie Verfuerth, Shirley D'Sa, et al.
British Journal of Haematology|December 14, 2011
Diffusion-weighted MRI compared to FDG PET-CT in the staging and response assessment of Hodgkin lymphomaMaria Marzolini, Wai L Wong, Kirit Ardeshna, et al.
Pageof 12

Showing results (1-10 of 114) with videos related to

Sort By:
Pageof 12
Frontiers in Oncology|November 19, 2024
Review of BCL2 inhibitors for the treatment of Waldenström's macroglobulinaemia and non-IgM lymphoplasmacytic lymphomaOliver Tomkins, Shirley D'Sa
Expert Review of Hematology|December 16, 2025
Avoiding serious treatment-emergent adverse events in Waldenström macroglobulinemia patientsJahanzaib Khwaja, Jessica Rodrigues, Shirley D'Sa
British Journal of Haematology|October 31, 2018
Advances in POEMS treatment and the need to define standardised outcome measuresStephen Keddie, Shirley D'Sa, Michael P Lunn
Immunotherapy|August 10, 2022
Sutimlimab for treatment of cold agglutinin disease: why, how and for whom?Sigbjørn Berentsen, Wilma Barcellini, Shirley D'Sa, et al.
British Journal of Haematology|August 7, 2022
Evidence-based medical treatment of POEMS syndromeJahanzaib Khwaja, Shirley D'Sa, Michael P Lunn, et al.
British Journal of Haematology|June 20, 2019
High-dose therapy and autologous transplantation for POEMS Syndrome: effective, but how to optimise?Oliver Tomkins, Stephen Keddie, Michael P Lunn, et al.
American Journal of Hematology|July 12, 2020
Daratumumab for disabling cold agglutinin disease refractory to B-cell directed therapyOliver Tomkins, Sigbjørn Berentsen, Suzanne Arulogun, et al.
British Journal of Haematology|March 16, 2007
Guidelines for the use of imaging in the management of myelomaShirley D'Sa, Niels Abildgaard, Jane Tighe, et al.
British Journal of Haematology|December 21, 2002
Assessing diversity: immune reconstitution and T-cell receptor BV spectratype analysis following stem cell transplantationKarl S Peggs, Stephanie Verfuerth, Shirley D'Sa, et al.
British Journal of Haematology|December 14, 2011
Diffusion-weighted MRI compared to FDG PET-CT in the staging and response assessment of Hodgkin lymphomaMaria Marzolini, Wai L Wong, Kirit Ardeshna, et al.
Pageof 12